Schizophrenia Drug
Drugmaker Allon Therapeutics is reporting that its new experimental drug for treating schizophrenia has shown promise in a mid-stage trial. In the study, schizophrenia patients who were given the medication showed improvement in levels of N-acetyl aspartate (NAA), an indicator of brain cell health. The medication failed to meet its end-stage goal in a previous mid-stage trial.
Read moreMore information on "Schizophrenia Drug"
From Our Experts
FDA Claims Pfizer Schizophrenia Drug Ad Misleading
The FDA has ruled that Pfizer violated the Federal Food, Drug and Cosmetic Act with a false or misleading advertisement in a medical... Read more »
Schizophrenia Drugs: The Latest Developments
This SharePost will be devoted to schizophrenia drugs in the pipeline. Bioline RX enrolled its first patient in their Phase II/III... Read more »
Schizophrenia Drugs: The Older Atypicals
This SharePost is the second in a series devoted to schizophrenia treatment and it focuses specifically on some of the atypical drugs used... Read more »
Are Alzheimer’s and Schizophrenia Related?
Medicalnewstoday.com reports that, in a study by neuroscientists at Johns Hopkins, mice "lacking an enzyme that contributes to Alzheimer's... Read more »
Schizophrenia: Latest Drug Treatments
This SharePost is the first of a series devoted to schizophrenia treatment and it focuses specifically on some of the newer drugs used to... Read more »
From Our Sources
New schizophrenia drug fails in trial
A new schizophrenia treatment that had shown great promise in earlier studies has failed to work better than a currently used medication or a placebo... Read more »
New schizophrenia drug's trial halted
Phase III clinical trials on a new drug to treat schizophrenia have been stopped, its makers report. Officials with drugmakers Lundbeck and Solvay... Read more »
FDA approves new schizophrenia drug
The U.S. Food and Drug Administration (FDA) has approved a new drug called Fanapt for the treatment of schizophrenia. FDA officials say Fanapt will... Read more »
Old schizophrenia drug safer than newer meds: study
Researchers in Finland have found that schizophrenia patients given the older drug clozapine (Clozaril) are less likely to die prematurely than those... Read more »
New Schizophrenia Drug Effective in New Trial
Danish drugmaker Lundbeck is reporting that its new schizophrenia medication zicronapine was effective in a recent Phase II clinical trial. In the... Read more »
Featuring Content From:
By using this service, you accept our Terms of Use. Please read them. The consumer health information on is for informational purposes only and is not a substitute for medical advice or treatment for any medical conditions. You should promptly seek professional medical care if you have any concern about your health, and you should always consult your physician before starting a fitness regimen. Copyright © 2012 Remedy Health Media, LLC. All Rights Reserved.
